RYHTY (Ryman Healthcare) Median PS Value: $43.52 (As of Jun. 24, 2026) — 5020% Above Median


RYHTY Ryman Healthcare Ltd RYHTY
70 GF Score
Price $6.11
GF Value $17.68
! 2 Warning Signs
View Full Analysis

What is Ryman Healthcare Median PS Value?

Ryman Healthcare RYHTY -12.82% 70 Median PS Value is $43.52 as of Jun. 24, 2026, which is 5020% above its 10-year median of 0.85. GuruFocus rates RYHTY with a GF Score™ of 70/100 and a GF Value™ of $17.68. The stock has 2 warning signs investors should review. Among 264 Healthcare Providers & Services companies, Ryman Healthcare ranks better than 96.97% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Ryman Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $2.987. Ryman Healthcare's 10-Year median PS Ratio is 14.5698. Therefore, the Median PS Value for today is $43.52.

As of today (2026-06-24), Ryman Healthcare's share price is $6.11. Ryman Healthcare's Median PS Value is $43.52. Therefore, Ryman Healthcare's Price to Median PS Value for today is 0.14.

The historical rank and industry rank for Ryman Healthcare's Median PS Value or its related term are showing as below:

RYHTY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14   Med: 0.85   Max: 1.46
Current: 0.14

During the past 13 years, the highest Price to Median PS Value of Ryman Healthcare was 1.46. The lowest was 0.14. And the median was 0.85.

RYHTY's Price-to-Median-PS-Value is ranked better than
96.97% of 264 companies
in the Healthcare Providers & Services industry
Industry Median: 0.71 vs RYHTY: 0.14

Ryman Healthcare  (OTCPK:RYHTY) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Ryman Healthcare's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=6.11/43.52
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ryman Healthcare Median PS Value Related Terms


Ryman Healthcare Median PS Value Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare Median PS Value Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.59 61.04 49.30 47.45 43.88

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.30 0.00 47.45 0.00 43.88

RYHTY vs HCA, THC, DVA: Median PS Value Comparison

For the Medical Care Facilities subindustry, Ryman Healthcare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryman Healthcare Price-to-Median-PS-Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Ryman Healthcare's Price-to-Median-PS-Value falls into.


RYHTY
70GF Score
Ryman Healthcare Ltd RYHTY
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryman Healthcare Median PS Value Calculation

Ryman Healthcare's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.987*14.5698
=43.52

10-Year Median PS Ratio is 14.5698.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $2.987.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of $43.52 mean?
Ryman Healthcare (RYHTY) has a Median PS Value of $43.52 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ryman Healthcare and its competitors. This is 5020% above median its historical median of 0.85. Over the past decade, Ryman Healthcare's Median PS Value has ranged from 0.14 to 1.46. According to the industry distribution chart, Ryman Healthcare ranks #8 out of 264 companies in the Healthcare Providers & Services industry, placing it in the top 3%.
Is Ryman Healthcare's Median PS Value too high?
Ryman Healthcare's current Median PS Value of $43.52 is 5020% above median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 1.46. The Healthcare Providers & Services industry median Median PS Value is 0.71. Ryman Healthcare's value of $43.52 is 6029.6% above this industry median. Based on the distribution chart, Ryman Healthcare ranks #8 out of 264 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #8 out of 264 companies for Median PS Value. This places Ryman Healthcare in the top 3% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Ryman Healthcare's value of $43.52 is 6029.6% above this benchmark. Historically, Ryman Healthcare's own Median PS Value has ranged from 0.14 to 1.46 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 0.71, Ryman Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ryman Healthcare's current Median PS Value of $43.52 is 6029.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ryman Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current Median PS Value is $43.52, which is 5020% above median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Median PS Value of $43.52. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current Median PS Value is $43.52, which is 5020% above median its 10-year median of 0.85 and 6029.6% above the Healthcare Providers & Services industry median of 0.71. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Median PS Value is $43.52 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ryman Healthcare (RYHTY) Overvalued in 2026?

Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued. The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.

Key valuation signals for RYHTY:

  • Median PS Value: $43.52 (5020% above median its 10-year median of 0.85)
  • GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
  • GF Score™: 70/100 with 2 warning signs
  • Industry Position: 6029.6% above the Healthcare Providers & Services median (#8 of 264)

No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ryman Healthcare Business Description

Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score

Get the complete analysis for RYHTY

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.11
Price
$17.68
GF Value